Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.

NCT00101686 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

547

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Neoplasms

Interventions

DRUG: Modified Bolus 5-FU/LV with Irinotecan
DRUG: FOLFIRI + bevacizumab
DRUG: miFL + bevacizumab
DRUG: Infusional 5-FU/LV with Irinotecan
DRUG: Oral Capecitabine with Irinotecan

Sponsor

Pfizer